TaurelFinance, decoded
Live
Loading market data…
TTaurel

Ultragenyx stock surges on FDA gene therapy approval

Investing.com· Investing.com· Aug 19, 2026 · 9:26 PM
Ultragenyx stock surges on FDA gene therapy approval

This is a summary. Read the complete story at Investing.com below.

Read full article at Investing.com

Related Stories

Russia stocks lower at close of trade; MOEX Russia Index down 1.93%
stocksabout 2 hours ago

Russia stocks lower at close of trade; MOEX Russia Index down 1.93%

Investing.com

Fitch cuts Flowers Foods rating to ’BB+’ on volume pressures
stocksabout 2 hours ago

Fitch cuts Flowers Foods rating to ’BB+’ on volume pressures

Investing.com

Fitch downgrades PG&E outlook on wildfire liability concerns
stocksabout 2 hours ago

Fitch downgrades PG&E outlook on wildfire liability concerns

Investing.com